82 related articles for article (PubMed ID: 1948998)
1. Effects of experimental hyper- and hypothyroidism on natural defense activities against Lewis lung carcinoma and its spontaneous pulmonary metastases in C57BL/6 mice.
Kinoshita S; Sone S; Yamashita T; Tsubura E; Ogura T
Tokushima J Exp Med; 1991 Jun; 38(1-2):25-35. PubMed ID: 1948998
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor effect of cepharanthin--mechanism of the antimetastatic effect on Lewis lung carcinoma (3LL)].
Ono M
Gan To Kagaku Ryoho; 1988 Feb; 15(2):249-55. PubMed ID: 3341787
[TBL] [Abstract][Full Text] [Related]
3. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
Isakov N; Feldman M; Segal S
Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
[TBL] [Abstract][Full Text] [Related]
4. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
5. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
Kalland T
Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.
Gorelik E; Fogel M; Segal S; Feldman M
J Supramol Struct; 1979; 12(3):385-402. PubMed ID: 94933
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
8. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
Isakov N; Feldman M; Segal S
J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.
Yamamoto T; Yamashita T; Tsubura E
Invasion Metastasis; 1981; 1(1):71-84. PubMed ID: 6234252
[TBL] [Abstract][Full Text] [Related]
10. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
Peppoloni S; Herberman RB; Gorelik E
Cancer Res; 1985 Jun; 45(6):2560-6. PubMed ID: 2580624
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
12. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
[TBL] [Abstract][Full Text] [Related]
13. Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin.
Cai KX; Tse LY; Leung C; Tam PK; Xu R; Sham MH
Clin Cancer Res; 2008 Feb; 14(3):939-49. PubMed ID: 18245558
[TBL] [Abstract][Full Text] [Related]
14. Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice.
Malavé I; Blanca I; Fuji H
J Natl Cancer Inst; 1979 Jan; 62(1):83-8. PubMed ID: 281579
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Ethylene Thiourea (CAS: 96-45-7) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1992 Mar; 388():1-256. PubMed ID: 12637971
[TBL] [Abstract][Full Text] [Related]
16. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
[TBL] [Abstract][Full Text] [Related]
18. Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma.
Yuhas JM; Pazmiño NH; Wagner E
Cancer Res; 1975 Jan; 35(1):237-41. PubMed ID: 162863
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
Chen J; Cao X; Xiu Q
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of hematogenous metastases in a murine model by natural killer cells.
Richie JP
Surgery; 1984 Aug; 96(2):133-8. PubMed ID: 6463854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]